Advertisement

Peptide Hormone Production Associated with Small Cell Lung Cancer

  • K. Havemann
  • W. Luster
  • C. Gropp
  • R. Holle
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 97)

Abstract

Small cell lung cancer (SCLC) is frequently associated with polypeptide hormone production, and a number of paraneoplastic syndromes have been reported. The neoplasia is thought to originate in the so-called Kulchitsky or K cells, small granular basal cells with endocrine properties found in the tracheobronchial mucosa (Tischler 1978). These K cells and the related SCLC and carcinoid tumor cells share APUD cell characteristics, such as cytoplasmic and membrane-bound dense core (“neurosecretory”) granules, amine precursor uptake and decarboxylation of precursors to biogenic amines by l-dopa decarboxylase, and storage of amines and polypeptide products in the neurosecretory granules (Pearse 1969). It has therefore been suggested that APUD cells and their tumors have a neuroepithelial origin different from the endodermal origin of the rest of the respiratory mucosa and its related neoplasia, such as squamous cell carcinoma and adenocarcinoma (Pearse 1969). However, morphological findings of foci of squamous carcinoma and adenocarcinoma in SCLC (Carney et al. 1982), the simultaneous appearance of histologically different multiple lung cancer (Gazdar et al. 1981), and ultrastructural evidence that SCLC cells may undergo squamous cell metaplasia (Mackay et al. 1977) favor the hypothesis that all bronchial mucosa cells and the tumors arising from them have a common origin. Although polypeptide hormone production is more frequently associated with SCLC, other types of lung cancer with non-APUD cell characteristics frequently show hormone secretion (Rose 1979). Furthermore, hormonal peptides are produced by a number of other solid tumors, by lymphomas, and by different types of leukemia (Pflüger et al. 1981, 1982).

Keywords

Small Cell Lung Cancer Small Cell Carcinoma Peptide Hormone Small Cell Lung Cancer Cell Small Cell Lung Cancer Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brereton HD, Matthews MJ, Costa M (1978) Mixed anaplastic small cell and squamous cell carcinoma of the lung. Ann Intern Med 88: 805–806PubMedGoogle Scholar
  2. Carney DN, Marangos PJ, Ihde DC (1982) Serum neuron-specific enolase: a marker of disease extent and response to therapy in patients with small cell lung cancer. Lancet 1: 583–585PubMedCrossRefGoogle Scholar
  3. Carney DN, Broder L, Edelstein M, Gazdar AF, Hansen M, Havemann K. Matthews MJ, Sorenson GD, Vindelov L (1983) Experimental studies of the biology of human small cell lung cancer. Cancer Treat Rep 67: 27–35PubMedGoogle Scholar
  4. Craig RK, Hall L, Edbrooke MR, Allison J, Maclntyre I (1982) Partial nucleotide sequence of human calcitonin precursor mRNA identifies flanking cryptic peptides. Nature 295: 345–347PubMedCrossRefGoogle Scholar
  5. Crine P, Ianoulakis C, Seidah NG, Gossard F, Pezalla PD, Chretien M (1978) Biosynthesis of ß-endorphin from ß-lipotropin and a larger molecular weight precursor in rat pars intermedia. Proc Natl Acad Sci USA 75: 4719–4722PubMedCrossRefGoogle Scholar
  6. Desplan C, Benicourt C, Jullienne A (1980) Cell free translation of mRNA coding for human and murine calcitonin. FEBS Lett 177: 89–92CrossRefGoogle Scholar
  7. Drings P, Holle R, Havemann K, Harms V (1983) The tumor markers CEA, calcitonin, and ACTH in a prospective trial of small cell lung cancer. In: Spitzy KH, Karrer K (eds) Proceedings 13th Int Congress Chemother, Vienna, 274: pp 45–48Google Scholar
  8. Gazdar AF, Carney DN, Guccion JG, Baylin SB (1981) Cellular origin and relationship to other lung tumors. In: Greco FA, Oldham RK, Bunn PA (eds) Small cell lung cancer. Grune and Stratton, New York, pp 145–176Google Scholar
  9. Greco AF, Hainsworth J, Sismann A (1981) Hormone production and paraneoplastic syndromes. In: Greco AF, Oldham RK, Bunn PA (eds) Small cell lung cancer. Grune and Stratton, New York, pp 177–224Google Scholar
  10. Gropp C, Luster W, Havemann K, Lehmann FG (1981) ACTH, calcitonin, a-MSH, ß-endorphin, parathormone and ß-HCG in sera of patients with lung cancer. In: Uhlenbruck G, Wintzer G (eds) CEA and andere Tumormarker. Tumor Diagnostik, Leonberg, pp 358–363Google Scholar
  11. Gropp C, Havemann K, Kalbfleisch H, Luster W, Sostmann H (1982) Antidiuretisches Hormon bei Patienten mit Bronchialkarzinom. Dtsch Med Wochenschr 107: 977–980CrossRefGoogle Scholar
  12. Gropp C, Luster W, Havemann K (1983) High molecular adrenocorticotropin and calcitonin immunoreactive proteins as biosynthesis products of small cell lung tumors. Acta Endocrinol [Suppl] (Copenh) 253: 16–17Google Scholar
  13. Hansen M, Hammer M, Hummer L (1980) ACTH, ADH, and calcitonin concentrations as marker of response and relapse in small cell carcinoma of the lung. Cancer 46: 2062–2067PubMedCrossRefGoogle Scholar
  14. Haskill S, Kivinen S, Nelson K, Fowler WC Jr (1983) Detection of intratumor heterogeneity by simultaneous multiparameter flow cytometric analysis with enzyme and DNA markers. Cancer Res 43: 1003–1009PubMedGoogle Scholar
  15. Havemann K, Gropp C (1979) Biological and immunological aspects of small cell carcinoma of the lung in relation to ectopic hormone production. Biomedicine 30: 186–194PubMedGoogle Scholar
  16. Havemann K, Gropp C, Scheuer A, Schärfe T, Gramse M (1979) ACTH-like activity in immune complexes of patients with oat-cell carcinoma of the lung. Br J Cancer 39: 43–50PubMedCrossRefGoogle Scholar
  17. Ihde DC, Hansen HH (1981) Staging procedures and prognostic factors in small cell carcinoma of the lung. In: Greco FA, Oldham RK, Bunn PA (eds) Small cell lung cancer. Grune and Stratton, New York, pp 261–284Google Scholar
  18. Jacobs JW, Lund PK, Potts JT, Bell NH Jr, Habener JF (1981) Procalcitonin is a glycoprotein. J Biol Chem 256: 2803–2807PubMedGoogle Scholar
  19. Krauss S, Macy S, Ichiki AT (1981) A study of immunoreactive calcitonin, ACTH and CEA in lung cancer and other malignancies. Cancer 47: 2485–2492Google Scholar
  20. Lips CJM, Van Der Sluys Veer J, Van Der Donk JA, Van Dam RH, Hackeng WHL (1978) CommonGoogle Scholar
  21. precursor molecule as origin for the ectopic hormone-producing tumor syndrome. Lancet 1: 16–18Google Scholar
  22. Luster W, Gropp C, Sostmann H, Kalbfleisch H, Havemann K (1982) Demonstration of immunoreactive calcitonin in sera and tissues of lung cancer patients. Eur J Cancer Clin Oncol 18: 1275–1283PubMedCrossRefGoogle Scholar
  23. Luster W, Gropp C, Havemann K (1983) Peptide hormone-synthesizing lung tumor cell lines: establishment and first characterization of biosynthetic products. Acta Endocrinol [Suppl] (Copenh) 102: 24–25Google Scholar
  24. Luster W, Gropp C, Havemann K (1983) Peptide hormone-synthesizing lung tumor cell lines: establishment and first characterization of biosynthetic products. Acta Endocrinol [Suppl] (Copenh) 102: 24–25Google Scholar
  25. Maclntyre I, Hillyard CJ, Murphy PK, Reynolds JJ, Gaines RE, Craig RK (1982) A second plasma calcium-lowering peptide from the human calcitonin precursor. Nature 300: 460–462CrossRefGoogle Scholar
  26. Mackay B, Osborne BM, Wilson RA (1977) Ultrastructure of lung neoplasma. In: Strauss MJ (ed) Lung cancer — clinical diagnosis and treatment. Grune and Stratton, New York, pp 71–84Google Scholar
  27. Mains RE, Eipper BA (1977) Coordinate synthesis of corticotropins and endorphins by mouse pituitary tumor cells. J Biol Chem 253: 651–655Google Scholar
  28. Mains RE, Eipper BA, Ling N (1977) Common precursor to corticotropins and endorphins. Proc Natl Acad Sci USA 74: 3014–3018PubMedCrossRefGoogle Scholar
  29. Marx JL (1983) Synthesizing the opioid peptides. Science 220: 395–397PubMedCrossRefGoogle Scholar
  30. Moody TW, Pert CB, Gazdar AF (1981) High levels of intracellular bombesin characterize human small cell lung carcinoma. Science 214: 1246–1248PubMedCrossRefGoogle Scholar
  31. Nakanishi S, Inoue A, Kita T, Nakamura M, Chany ACY, Cohen SN, Numa S (1979) Nucleotide sequence of cloned cDNA for bovine corticotropin-ß-lipotropin precursor. Nature 278: 423–427PubMedCrossRefGoogle Scholar
  32. North WG, Maurer H, Valtin H, O’Donell JF (1980) Human neurophysins as potential tumor markers for small cell carcinoma of the lung: Application of specific radioimmunoassays. J Clin Endocrinol Metab 51: 892–897Google Scholar
  33. Odell WD, Wolfsen AF, Yoshimoto Y (1977) Ectopic peptide synthesis: a universal concomitant of neoplasia. Trans Assoc Am Physicians 40: 204–225Google Scholar
  34. Odell WD, Wolfsen AR, Bachelot I, Hirose FM (1979) Ectopic production of lipotropin by cancer. Am J Med 66: 631–638PubMedCrossRefGoogle Scholar
  35. Pearse AGE (1969) The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J Histochem Cytochem 17: 303PubMedCrossRefGoogle Scholar
  36. Pflüger KH, Gramse M, Gropp C, Havemann K (1981) Ectopic ACTH production with autoantibody formation in a patient with acute myeloblastic leukemia. N Engl J Med 305: 1632–1636PubMedCrossRefGoogle Scholar
  37. Pflüger KH, Gropp C, Havemann K (1982) Ectopically produced calcitonin in human hemoblastoses. Klin Wochenschr 60: 667–672PubMedCrossRefGoogle Scholar
  38. Ratcliffe JG, Podmore J, Stack BHR, Spilg WGS, Gropp C (1982) Circulating ACTH and related peptides in lung cancer. Br J Cancer 45: 230–238PubMedCrossRefGoogle Scholar
  39. Roos BA, Okano K, Deftos LJ (1974) Evidence for a procalcitonin. Biochem Biophys Res Commun 60: 1134–1140PubMedCrossRefGoogle Scholar
  40. Rose DP (1979) The ectopic production of hormones by tumors. In: Rose DP (ed) Endocrinology of cancer II. CRC Press, Boca Raton, pp 95–124Google Scholar
  41. Roth J, LeRoith D, Shiloach J (1982) The evolutionary origin by hormones, neurotransmitters and other extracellular chemical messengers. N Engl J Med 306: 523–527PubMedCrossRefGoogle Scholar
  42. Sherwin SA, Todaro GJ (1983) Transforming growth factors and human lung cancer. In: Greco FA (ed) Biology and management of human lung cancer. Martinus Nighoff, Boston, pp 37–50CrossRefGoogle Scholar
  43. Takahasi H, Teranishi Y, Nakanishi S, Numa S (1981) Isolation and structural organization of the human corticotropin-ß-lipotropin precursor gene. FEBS Lett 135: 97–102CrossRefGoogle Scholar
  44. Tanaka K, Nicholson WE, Orth DN (1978) The nature of the immunoreactive lipotropins in human plasma and tissue extracts. J Clin Invest 62: 94–104PubMedCrossRefGoogle Scholar
  45. Tischler AS (1978) Small cell carcinoma of the lung, cellular origin and relationship to other neoplasms. Semin Oncol 5: 244PubMedGoogle Scholar
  46. Todaro GJ, Sporn MB (1980) Autocrine secretion and malignant transformation of cells. N Engl J Med 303: 878–890PubMedCrossRefGoogle Scholar
  47. Vindelov L, Hansen HH, Christensen IJ, Spang-Thomasen M, Hirsch FR, Hansen M, Nissen NI (1980) Clonal heterogeneity of small cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis. Cancer Res 40: 4295–4300PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1985

Authors and Affiliations

  • K. Havemann
    • 1
  • W. Luster
    • 1
  • C. Gropp
    • 1
  • R. Holle
    • 1
  1. 1.Abteilung Hämatologie/Onkologie, Zentrum für Innere MedizinUniversität MarburgMarburgFederal Republic of Germany

Personalised recommendations